ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102051 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102051; 2) Community: the network communities that were significantly associated with the response to NSC 102051; 3) Molecule: the relationships between components within communities and NSC 102051; 4) MDR: the compounds that were significantly associated with the NSC 102051.

NSC Compound Enrichment Correlation
NSC 707691 Null 0.0208632511155816 0.1650003
NSC 711104 Null 0.0208632511155816 0.24290599
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0208632511155816 0.26984027
NSC 736179 1,2-Dithiolan-3-yl-N-(3'-methoxyestra-1',3',5'(10')-triene-1 7'b-yl)pentanamide 0.0208632511155816 -0.084972672
NSC 736493 Indenoisoquinoline derivative 0.0208632511155816 0.27469213
NSC 673104 Null 0.0210461623330205 0.36536405
NSC 682242 6H-Purin-6-one, 1,2,3,9-tetrahydro- 9-(tetrahydro-2-pyranyl)-1,3-diphenyl-2-thioxo- 0.0210461623330205 0.32503922
NSC 715740 Null 0.0210461623330205 0.20386782
NSC 307241 Adriamycin deriv., mixt. with hydroxyethyl starch (cross-linked) 0.0219024304994663 0.13077414
NSC 682520 9H-Purine, 2,6-dibromo-9-[2-deoxy- 3,5-O-bis(4-methylphenyl)-.alpha.-D-erythro- pentofuranosyl]- 0.0219024304994663 -0.11702675
Total:49  Current:20    [First] [Prev] [Next] [Last]